Belgium· BE-AMP-SAM662272-00

Velsipity 2 mg

A etrasimod product containing etrasimod arginine, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 13 of our 19 countries.

ATC L04AE05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVelsipity 2 mgATCL04AE05REGISTER NO.BE-AMP-SAM662272-00PACKS LISTED4CHECKEDSeptember 26, 2026

Where it is registered

Etrasimod is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AE05 (etrasimod), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Etrasimod · ATC L04AE05

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etrasimod costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Etrasimod · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$35.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Etrasimod Arginine
Manufacturer
Pfizer Europe MA
Country
Belgium (BE)
ATC code
L04AE05
ATC class
Etrasimod
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

2 priced
  • be_apb
    4694204
    EUR 2435.35
  • be_apb
    5861133
    EUR 2435.35
  • be_apb
    7741754
  • be_apb
    7750102

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/339cb33e-7782-4e9c-ab43-bf73bd5cd9bd
GET /v1/drugs/339cb33e-7782-4e9c-ab43-bf73bd5cd9bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Velsipity 2 mg",
  "name_fr": "Velsipity 2 mg",
  "name_nl": "Velsipity 2 mg",
  "amp_code": "SAM662272-00",
  "strengths": [
    "2.0000",
    "2.0000",
    "0.0156"
  ],
  "pack_count": 4,
  "substances": [
    "Etrasimod Arginine",
    "Etrasimod",
    "Mannitol",
    "Sodium Starch Glycolate (Type A)",
    "Tartrazine Aluminium Lake"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Etrasimod",
  "authorisation_numbers": [
    "EU/1/23/1790/001",
    "EU/1/23/1790/002",
    "EU/1/23/1790/003"
  ]
}

See everything about etrasimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.